Brief: Immunovia Provides Update On Its Lung Cancer Pipeline Projects

Immunovia AB (publ)

02/10/2019 07:35

Oct 2 (Reuters) - Immunovia AB (publ)  IMMNOV.ST :
    * IMMUNOVIA PROVIDES AN UPDATE ON ITS LUNG CANCER PIPELINE
PROJECTS
    * IMMRAY™ COULD DIFFERENTIATE HEALTHY CONTROLS FROM
NON-SMALL CELL
LUNG CANCER (NSCLC) WITH AN 95% ACCURACY
    * PROGRESS WITH OUR PHARMA COLLABORATION HAS MOVED SOMEWHAT
SLOWER
THAN ORIGINALLY ANTICIPATED
    * HOWEVER, STEADY PROGRESS IS BEING MADE AND WE REMAIN VERY
POSITIVE WITH THIS JOINT EFFORT

Source text for Eikon:  ID:nWkr9snQNv 
Further company coverage:  IMMNOV.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))